Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | EVP & Chief Legal & Admin Off. | August 26, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date August 26, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy 2026 GRAT | 0 |
Reported balance
After 2026-08-26 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-26 · Other · Disposed 7,769 · Balance 0 F1: Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust. |
| Common StockSEC Table I · non-derivative | Direct | 1,084 |
Reported balance
Holding disclosure · report date 2026-08-26 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,084 F1: Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust. |
| Common StockSEC Table I · non-derivative | IndirectBy 2026 GRAT II | 7,769 |
Reported balance
Holding disclosure · report date 2026-08-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 7,769 F1: Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust. |
| Common StockSEC Table I · non-derivative | IndirectBy 2024 GRAT | 2,111 |
Reported balance
Holding disclosure · report date 2026-08-26 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,111 |
| Common StockSEC Table I · non-derivative | IndirectBy managed account | 26 |
Reported balance
Holding disclosure · report date 2026-08-26 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 26 F2: The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust.
F2: The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 28, 2026 17:00 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock | 7,769 | $429.00 | $3,332,901.00 |
DisclosureSEC source: 0001193125-26-374693 · ownership.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Indirect · By 2026 GRAT Disclosed balance after: 0 F1 · kind: Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust. Read SEC document |
| February 18, 2026 Filed Feb 18, 2026 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,694 | $533.37 | $903,536.74 |
DisclosureSEC source: 0001193125-26-057701 · ownership.xml · nonDerivative · entry 3 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,853 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 5,000 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001193125-26-057701 · ownership.xml · derivative · entry 6 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,860 Underlying: Common Stock · 5,000 shares Expires 2032-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,306 | $540.29 | $1,786,198.74 |
DisclosureSEC source: 0001193125-26-057701 · ownership.xml · nonDerivative · entry 2 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,547 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 5,000 | $236.61 | $1,183,050.00 |
DisclosureSEC source: 0001193125-26-057701 · ownership.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,006 | $502.05 | $1,509,162.30 |
DisclosureSEC source: 0001193125-26-049217 · ownership.xml · nonDerivative · entry 2 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,853 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 8,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-049217 · ownership.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,859 F1 · kind: On January 30, 2023, the reporting person was granted 4,186 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 18:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 8,067 | $0.00 Strike: $482.53 | $0.00 |
DisclosureSEC source: 0001193125-26-034008 · ownership.xml · derivative · entry 1 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,067 Underlying: Common Stock · 8,067 shares Expires 2036-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 18:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 3,892 | $473.79 | $1,843,990.68 |
DisclosureSEC source: 0001193125-25-267409 · ownership.xml · nonDerivative · entry 3 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,487 Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 18:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 13,170 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001193125-25-267409 · ownership.xml · derivative · entry 6 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,170 shares Expires 2032-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in two equal annual installments beginning on January 28, 2023. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 18:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 9,278 | $461.56 | $4,282,353.68 |
DisclosureSEC source: 0001193125-25-267409 · ownership.xml · nonDerivative · entry 2 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,379 Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 18:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 13,170 | $236.61 | $3,116,153.70 |
DisclosureSEC source: 0001193125-25-267409 · ownership.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 531 | $321.92 | $170,939.52 |
DisclosureSEC source: 0000950170-25-022664 · ownership.xml · nonDerivative · entry 2 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,696 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022664 · ownership.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,227 F1 · kind: On January 28, 2022, the reporting person was granted 4,080 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 18:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 11,171 | $0.00 Strike: $328.70 | $0.00 |
DisclosureSEC source: 0000950170-25-011260 · ownership.xml · derivative · entry 4 McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,171 Underlying: Common Stock · 11,171 shares Expires 2035-01-28 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026. Read SEC document |
| April 29, 2024 Filed May 1, 2024 18:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 2,274 | $0.00 Strike: $311.42 | $0.00 |
DisclosureSEC source: 0001209191-24-005444 · doc4.xml · derivative · entry 1 McAlevey Michael R · CIK 0001907875 · EVP - Chief Legal & Admin Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,274 Underlying: Common Stock · 2,274 shares Expires 2034-04-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on April 29, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 11,005 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002726 · doc4.xml · derivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,005 Underlying: Common Stock · 11,005 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| January 28, 2024 Filed Jan 30, 2024 19:22 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002455 · doc4.xml · derivative · entry 4 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,940 shares Expires 2032-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vested in two equal annual installments beginning on January 28, 2023. Read SEC document |
| January 28, 2024 Filed Jan 30, 2024 19:22 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 489 | $283.43 | $138,597.27 |
DisclosureSEC source: 0001209191-24-002455 · doc4.xml · nonDerivative · entry 2 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,012 Read SEC document |
| January 28, 2024 Filed Jan 30, 2024 19:22 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002455 · doc4.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 12,630 | $0.00 Strike: $253.30 | $0.00 |
DisclosureSEC source: 0001209191-23-006036 · doc4.xml · derivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,630 Underlying: Common Stock · 12,630 shares Expires 2033-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. Read SEC document |
| January 28, 2023 Filed Jan 31, 2023 18:58 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-005806 · doc4.xml · derivative · entry 4 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 1,940 shares Expires 2032-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in two equal annual installments beginning on January 28, 2023. Read SEC document |
| January 28, 2023 Filed Jan 31, 2023 18:58 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 489 | $254.77 | $124,582.53 |
DisclosureSEC source: 0001209191-23-005806 · doc4.xml · nonDerivative · entry 2 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,561 Read SEC document |
| January 28, 2023 Filed Jan 31, 2023 18:58 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-005806 · doc4.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 29, 2022 Filed May 3, 2022 17:59 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock | 1,110 | $218.56 | $242,602.04 |
DisclosureSEC source: 0001209191-22-026849 · doc4.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,110 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $218.10 to $218.90, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:29 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantRestricted Stock Units · Derivative | 3,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006078 · doc4.xml · derivative · entry 3 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,880 Underlying: Common Stock · 3,880 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in two equal annual installments beginning on January 28, 2023. F4 · derivative.expiration_date: The restricted stock units vest in two equal annual installments beginning on January 28, 2023. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:29 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 13,170 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-22-006078 · doc4.xml · derivative · entry 2 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,170 Underlying: Common Stock · 13,170 shares Expires 2032-01-28 F2 · derivative.exercise_date: The stock appreciation rights vest in two equal annual installments beginning on January 28, 2023. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:29 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 13,860 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-22-006078 · doc4.xml · derivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,860 Underlying: Common Stock · 13,860 shares Expires 2032-01-28 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.